Waiting Time to Cancer Progression
Author Information
Author(s): Niko Beerenwinkel, Tibor Antal, David Dingli, Arne Traulsen, Kenneth W. Kinzler, Victor E. Velculescu, Bert Vogelstein, Martin A. Nowak
Primary Institution: Harvard University
Hypothesis
How do genetic mutations influence the waiting time for cancer progression?
Conclusion
The study concludes that cancer progression can occur with a normal mutation rate if the average selective advantage per mutation is around 1%.
Supporting Evidence
- The model predicts that observed genetic diversity in cancer genomes can arise under normal mutation rates.
- Increased mutation rates can lead to faster cancer progression even with smaller selective advantages.
- The study highlights the importance of selection in cancer evolution.
Takeaway
Cancer grows when cells make mistakes in their DNA. This study shows that even small changes can help cancer grow over time.
Methodology
The study uses a mathematical model based on the Wright-Fisher process to analyze the evolution of cancer in colorectal adenomas.
Limitations
The model assumes that all mutations confer the same selective advantage and does not account for the complexity of gene interactions.
Participant Demographics
The study analyzed tumor samples from 35 patients with advanced colorectal cancers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website